EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis

Franziska Fries iD, Jennifer Herrmann, Michael Dal Molin, Yaëlle Wormser, Timo Risch, Yunsheng Gao, Gareth Prosser, Francesca Gubellini, Ariel Mechaly, Joshua B Wallach, Anthony Castro, Arka Banerjee iD and 14 more

Advanced Science · 2026-11 · 13 (63)

DOI: 10.1002/advs.76832 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-10. Written by Franziska Fries and 25 co-authors. Institution: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland U…. Major MEDLINE topics: Mycobacterium tuberculosis, Fluoroquinolones, DNA Gyrase, Biological Products. 79 references. The full text is freely available (open access, CC BY 4.0). Funded by: German Center for Infection Research, Gates Foundation, Bill & Melinda Gates Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Despite significant advancements in drug development and discovery, tuberculosis remains one of the world's deadliest infectious diseases. The rise and global spread of multidrug‐resistant strains underscore a critical need for new antibiotics with distinct mechanisms of action. Screening of a myxobacterial extract library uncovered the previously unrecognized antitubercular activity of corramycin, a natural product with potent bactericidal activity against both drug‐sensitive and ‐resistant Mycobacterium tuberculosis . Corramycin enters the bacterial cell by exploiting multiple transport systems, and induces DNA double‐strand breaks through a novel form of DNA gyrase poisoning. The cryo‐electron microscopy structure of M. tuberculosis gyrase in complex with corramycin reveals that the natural product targets a site overlapping with the binding site of synthetic fluoroquinolones, thereby locking the gyrase in an inactive conformation and preventing re‐ligation of DNA. Importantly, its unique mode of binding allows corramycin to overcome fluoroquinolone resistance, highlighting its promise as a novel antibiotic scaffold to address the antimicrobial resistance crisis.

Subjects

MeSH terms (MEDLINE)

Mycobacterium tuberculosisFluoroquinolonesDNA GyraseBiological ProductsAntitubercular AgentsDrug Resistance, BacterialTopoisomerase II InhibitorsHumansPeptides

Author keywords

DNA synthesis inhibitorMycobacterium tuberculosiscryo‐EMgyrase poisonmechanism of actionnatural products

Substances

FluoroquinolonesDNA GyraseBiological ProductsAntitubercular AgentsTopoisomerase II InhibitorscorramycinPeptides

Authors and institutions

  • Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.
  • German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.
  • Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Institut Pasteur, Université Paris Cité, CNRS UMR 3528, Bacterial Cell Cycle Mechanisms Unit, Paris, France.

ORCID profiles: Franziska Fries, Arka Banerjee

Funding

  • German Center for Infection Research
  • Gates Foundation
  • Bill & Melinda Gates Foundation
  • French National Research Agency
  • German Research Foundation
  • Deutsches Zentrum für Infektionsforschung
  • Deutsche Forschungsgemeinschaft
  • Agence Nationale de la Recherche

Cite

APA

Fries, F., Herrmann, J., Dal Molin, M., Wormser, Y., Risch, T., Gao, Y., Prosser, G., Gubellini, F., Mechaly, A., Wallach, J. B., Castro, A., Banerjee, A., Rasheed, S., Horn, A., Müsken, M., Kurz, M., Sonnenkalb, L., Dreyer, V., Niemann, S., …, & Petrella, S. (2026). The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis. Advanced Science, 13(63). https://doi.org/10.1002/advs.76832

Vancouver

Fries F, Herrmann J, Dal Molin M, Wormser Y, Risch T, Gao Y, et al. The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis. Advanced Science. 2026;13(63). doi:10.1002/advs.76832

BibTeX
@article{Fries2026,
  author = {Fries, Franziska and Herrmann, Jennifer and Dal Molin, Michael and Wormser, Yaëlle and Risch, Timo and Gao, Yunsheng and Prosser, Gareth and Gubellini, Francesca and Mechaly, Ariel and Wallach, Joshua B and Castro, Anthony and Banerjee, Arka and Rasheed, Sari and Horn, Alexander and Müsken, Mathias and Kurz, Michael and Sonnenkalb, Lindsay and Dreyer, Viola and Niemann, Stefan and Andres, Sönke and Schnappinger, Dirk and Kazmaier, Uli and Reiling, Norbert and Müller, Rolf and Rybniker, Jan and Petrella, Stéphanie},
  title = {The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {63},
  doi = {10.1002/advs.76832}
}
Start for free →